Overview

Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression

Status:
Terminated
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of different doses of Lu AA34893 in the treatment of depression in patients with bipolar disorder.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lundbeck A/S
Treatments:
Quetiapine Fumarate